March 10, 1995
A federal court Thursday awarded $2.7 million to Comprehensive Care Corp. to settle a lawsuit the company had filed against a former subsidiary. In October, 1992, Comprehensive Care sued RehabCare Corp. in U.S. District Court in Missouri, alleging violations of a securities agreement. RehabCare was approached by a potential buyer, according to the suit, but refused to negotiate an acquisition.
November 17, 1987 |
Comprehensive Care Corp., the nation's largest provider of alcohol and drug abuse treatment programs, said Monday it plans to restructure into two companies in an attempt to boost earnings and the market value of its stock, both of which have dropped in recent years. B. Lee Karns, chairman and chief executive officer of the Irvine-based firm, also said Comprehensive Care intends to sell stock in its physical rehabilitation unit, called Rehabcare Corp.
January 13, 1989
ADDRESS: 18551 Von Karman Ave., Irvine BUSINESS: Develops and manages programs for treatment of alcoholism and psychiatric treatment. Provides rehabilitation therapy services. Operates long-term care facilities. ASSETS: $229.9 million (May 31, 1988) NUMBER OF EMPLOYEES: NA TOP EXECUTIVES: Cash Name Position Compensation B. Lee Karns Chairman, chief executive officer $488,449 James P. Carmany Executive vice president $151,489 Robert L. Kasselmann Executive vice president $210,166 William J.
February 6, 1990 |
Comprehensive Care Corp., the financially ailing alcohol and drug treatment company that recently moved its headquarters from Irvine to St. Louis, said Monday that B. Lee Karns has stepped down as chairman. The resignation accomplishes Karns' previously announced plans to withdraw from company affairs. Karns, 60, resigned in October as Comp Care's chief executive officer. Karns had been chairman since 1972 and will remain on the company board of directors. "Mr.
March 1, 1987 |
One of the better stock plays among Orange County companies may be a bond investment. Last week, Microsemi Corp. sold $35 million in debentures that are convertible to shares of the Santa Ana-based semiconductor products maker. Paying 5 7/8% annual interest, the debentures are convertible into common stock at $13.55 a share. That's well over Friday's closing price in over-the-counter trading of $11.50 a share.